LY2334737

Item number	Size	Delivery time	Price
TGM-T4061-1mg	1 mg	7 - 10 business days*	63.00€
TGM-T4061-5mg	5 mg	7 - 10 business days*	156.00€
TGM-T4061-1mL	1 ml	7 - 10 business days*	167.00€
TGM-T4061-10mg	10 mg	7 - 10 business days*	237.00€
TGM-T4061-25mg	25 mg	7 - 10 business days*	395.00€
TGM-T4061-50mg	50 mg	7 - 10 business days*	591.00€
TGM-T4061-100mg	100 mg	7 - 10 business days*	817.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: LY2334737 is an orally available prodrug of gemcitabine with antineoplastic... more

Close menu

Product information "LY2334737"

Description: LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity. Target: Virus Protease, Others, Nucleoside Antimetabolite/Analog. Smiles: CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1. References: Pratt SE, et al. Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells. Clin Cancer Res. 2013 Mar 1,19(5):1159-68.

Supplier:	TargetMol
Supplier-Nr:	T4061

Properties

Application:	Gemcitabine prodrug form
MW:	389.39 D
Formula:	C17H25F2N3O5

Database Information

CAS :	892128-60-8\| Matching products
KEGG ID :	K10807 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "LY2334737"

Write a review